Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference65 articles.
1. Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells
2. Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma
3. Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein (XIAP)
Cited by 148 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Extracellular vesicles of Bifidobacterium longum reverse the acquired carboplatin resistance in ovarian cancer cells via p53 phosphorylation on Ser15;The Kaohsiung Journal of Medical Sciences;2024-04-22
2. A first-in-human phase I study of TAS-117, an allosteric AKT inhibitor, in patients with advanced solid tumors;Cancer Chemotherapy and Pharmacology;2024-02-27
3. CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination;Journal of Nanobiotechnology;2024-01-19
4. AI-aided high-throughput profiling of single-cell migration and proliferation on addressable dual-nested microwell arrays;Cell Reports Physical Science;2023-02
5. Integrin α6β4 signals through DNA damage response pathway to sensitize breast cancer cells to cisplatin;Frontiers in Oncology;2022-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3